Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antioxidant supplementation for sickle cell disease

Cochrane Database of Systematic Reviews(2024)10.1002/14651858.cd013590.pub2Source: DataRank Database

Antioxidant supplementation for sickle cell disease is a research paper published in Cochrane Database of Systematic Reviews (2024). On theSindex it has a DataRank of 0.399. It has been cited 9 times, with 8 citing works in its 1-hop citation network.

N/A

0.399DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access9 citations · 8 citing works in its network

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT00125788 NCT01179217 NCT00513617 NCT03528434 NCT01202812 NCT04839354

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: bronzeTopics (33)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 87%Citation Network 13%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

0.0531

From 5 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 8 citers.

LC-MS/MS Analysis of crude Flavonoid Compounds from Justicia secunda from Democratic Republic of the Congo and evaluation of their antisickling Activity
Natural Resources for Human Health20243 citations53 referencesContributes 0.026
The effects of nutritional supplementation for children and adolescents with sickle cell disease: A systematic review and meta-analyses
Clinical Nutrition20254 citations97 referencesContributes 0.017
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
Frontiers in Hematology20251 citations70 referencesContributes 0.010
New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine
Antioxidants20255 citations363 referencesContributes 0.005
Beyond ATP: Metabolite Networks as Regulators of Physiological and Pathological Erythroid Differentiation
Physiology20242 citations223 referencesContributes 0.005

Authors (6)

Olabisi Oduwole ORCID,Joseph Okebe ORCID,Ann Ogbenna ORCID,Oluwakemi Otokiti,A T Olatinwo

Live enrichment

PubMed:38775255

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 2M01RR000533-30

IMPACT OF PRIMARY CARE ON SUBSTANCE ABUSING PATIENTS IN DETOXIFICATION UNIT

National Institutes of Health

Grant: 1R01FD003531-01

Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension

National Institutes of Health

Grant: 3UL1TR001878-06S1

Institutional Clinical and Translational Science Award

National Institutes of Health

Grant: 5KL2RR024132-03

Institutional Clinical and Translational Science Award

National Institutes of Health

Grant: 5K23HL004386-02

ARGININE THERAPY IN SICKLE CELL DISEASE

National Institutes of Health

Grant: 2K24AT009893-06

Patient-Oriented Research in Arginine Deficiency Syndromes

National Institutes of Health

Grant: 5R01AM031401-03

ABSORPTION, TURNOVER, &BIOCHEMICAL STUDIES OF ZN IN MAN

National Institutes of Health

Grant: 3UL1RR024131-03S3

Clinical and Translational Science Institute

National Institutes of Health

Grant: 5U54HL070596-04

Approaches to increase gamma-Globulin Expression in Sickle Cell Disease

National Institutes of Health

Grant: 1ZIAHL006017-04

Niacin Therapy to Improve Endothelial Function in SCD

National Institutes of Health

Grant: 3UL1RR024134-06S2

Institutional Clinical and Translational Science Award

bronzeLicense: cc-by-nc

publisherhttps://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013590.pub2/pdf/full

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11110109/pdf/CD013590.pdf

https://doi.org/10.1002/14651858.cd013590.pub2

https://doi.org/10.1002/14651858.cd013590

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197651

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesHumansAnemia, Sickle CellAntioxidantsAscorbic AcidBiasDietary SupplementsOxidative StressPlacebosQuality of LifeRandomized Controlled Trials as Topic

MeSH Terms

HumansAnemia, Sickle CellAntioxidantsAscorbic AcidBiasDietary SupplementsOxidative StressPlacebosQuality of LifeRandomized Controlled Trials as Topic

Keywords

Anemia, Sickle CellAscorbic AcidAntioxidantsPlacebosOxidative StressBiasDietary SupplementsQuality of LifeHumansRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good health